214
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 1963-1970 | Published online: 07 Sep 2021

References

  • Kourlaba G, Kourkouni E, Maistreli S, et al. Willingness of Greek general population to get a COVID-19 vaccine. Glob Health Res Policy. 2021;6(1):1–10. doi:10.1186/s41256-021-00188-1
  • Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21:475–484. doi:10.1038/s41577-021-00578-z
  • National Center for Immunization and Respiratory Diseases.  Centers for Disease Control and Prevention. Interim clinical considerations for use of covid-19 vaccines are currently authorized in the United States. [updated May 6, 2021]. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html. Accessed May 17, 2021
  • Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health. 2020;13:834–838. doi:10.1016/j.jiph.2020.04.016
  • Saudi Arabia to make coronavirus vaccine free for citizens and residents. Arab News; 2020. Available from: https://arab.news/8u269. Accessed May 17, 2021.
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577
  • Voysey M, Clemens SAC, Madhi SA, et al. safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the U.K. Lancet. 2021;397:99–111. doi:10.1016/S0140-6736(20)32661-1
  • Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the U.K.: a prospective observational study. Lancet Infect Dis. 2021;21:939–945. doi:10.1016/S1473-3099(21)00224-3
  • El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389–1401. doi:10.2147/IJGM.S310497
  • Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663–1669. doi:10.26355/eurrev_202102_24877
  • Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418–4421. doi:10.26355/eurrev_202106_26153
  • Beattie M, Murphy DJ, Atherton I, et al. Instruments to measure patient experience of healthcare quality in hospitals: a systematic review. Syst Rev. 2015;4:97. doi:10.1186/s13643-015-0089-0
  • Mathers N, Fox N, Hunn A. Surveys and questionnaires. The NIHR Research Design Service for Yorkshire & the Humber. [updated March 11, 2009]. Available from: https://www.rds-yh.nihr.ac.uk/wpcontent/uploads/2013/05/12_Surveys_and_Questionnaires_Revision_2009.pdf. Accessed July 12, 2021. 
  • Artino AR Jr, La Rochelle JS, Dezee KJ, et al. Developing questionnaires for educational research: AMEE Guide No. 87. Med Teach. 2014;36(6):463–474. doi:10.3109/0142159X.2014.889814
  • Ministry of Health – Kingdom of Saudi Arabia. MOH publications: COVID-19 guidelines. [updated July 7, 2021]. Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Pages/365 covid19.aspx. Accessed July 17, 2021
  • King Abdullah Petroleum Studies and Research Center. Saudi Arabia Coronavirus disease (COVID-19) situation. [updated April 17, 2021]. Available from: https://datasource.kapsarc.org/explore/dataset/saudi-arabia-coronavirus-disease-covid-19-situation-demographics/. Accessed May 12, 2021.
  • Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. Lancet. 2011;378(9790):526–535. doi:10.1016/S0140-6736(11)60678-8
  • Gust DA, Woodruff R, Kennedy A, Brown C, Sheedy K, Hibbs B. Parental perceptions surrounding risks and benefits of immunization. Semin Pediatr Infect Dis. 2003;14:207–212. doi:10.1016/S1045-1870(03)00035-9
  • World health organization: Coronavirus disease (COVID-19): Vaccines safety. [updated February 17, 2021].  Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines-safety.  Accessed July 29, 2021.
  • Hatmal MM, Al-Hatamleh MA, Olaimat AN, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: a Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines. 2021;9(6):556. doi:10.3390/vaccines9060556
  • Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Kluger M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. doi:10.3390/jcm10071428
  • Kadali RAK, Janagama R, Peruru S, et al. Adverse effects of COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol. 2021;93(7):4420–4429. doi:10.1002/jmv.26996
  • Kadali RAK, Janagama R, Perry S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021;106:376–381. doi:10.1016/j.ijid.2021.04.047
  • Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA. 2021;325(21):2201. doi:10.1001/jama.2021.5374
  • Alhazmi A, Alamer E, Daws D, et al. Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines. 2021;9(6):674. doi:10.3390/vaccines9060674
  • Kesselheim AS, Darrow JJ, Kulldorff M, et al. An overview of vaccine development, approval, and regulation, with implications for COVID-19: analysis reviews the Food and Drug Administration’s critical vaccine approval role with implications for COVID-19 vaccines. Health Aff. 2021;40(1):25–32. doi:10.1377/hlthaff.2020.01620